These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9424645

  • 1. [Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results].
    Bartolozzi C, Lencioni R, Armillotta N.
    Radiol Med; 1997; 94(1-2):19-23. PubMed ID: 9424645
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma].
    Chen XM, Luo PF, Lin HH, Zhou ZJ, Shao PJ, Fu L, Li WK.
    Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922
    [Abstract] [Full Text] [Related]

  • 4. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

  • 5. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Diagnostic imaging and interventional therapy in hepatocarcinoma. Multicenter study of 290 cases].
    Dalla Palma L, Pozzi Mucelli R, Sponza M, Bartolozzi C, Lencioni R, Florio F, De Santis M, Gandini G, Matricardi L, Rossi C, Simonetti G, Pocek M.
    Radiol Med; 1997 Dec; 94(1-2):30-6. PubMed ID: 9424647
    [Abstract] [Full Text] [Related]

  • 10. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG, Yoon CJ, Jeong SH, Kim JW, Lee SH, Lee KH, Kim YH.
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [Abstract] [Full Text] [Related]

  • 11. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK, Wikström M, Flechtenmacher C, Filser T, Dueber C.
    Cardiovasc Intervent Radiol; 2006 Dec; 29(5):778-84. PubMed ID: 16779690
    [Abstract] [Full Text] [Related]

  • 12. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [Abstract] [Full Text] [Related]

  • 13. Treatment of large hepatocellular carcinoma: comparison between techniques and long term results.
    Ferrari FS, Stella A, Gambacorta D, Magnolfi F, Fantozzi F, Pasquinucci P, Civeli L, Pieraccini M.
    Radiol Med; 2004 Oct; 108(4):356-71. PubMed ID: 15525889
    [Abstract] [Full Text] [Related]

  • 14. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y, Balkanci F, Kayhan B, Uzunalimoglu B, Gokoz A, Ozisik Y, Gurakar A, Van Thiel DH, Firat D.
    Hepatogastroenterology; 1996 Oct; 43(9):681-7. PubMed ID: 8799415
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of primary hepatocarcinoma with chemoembolization and alcohol injection. Personal experience].
    Florio F, Nardella M, Balzano S, Andriulli A, Caturelli E, Siena D, Bisceglia M, Fusilli S, Scarale MG, Cammisa M.
    Radiol Med; 1994 Dec; 88(6):821-6. PubMed ID: 7878242
    [Abstract] [Full Text] [Related]

  • 16. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D, Sponza M, Marzio A, Zanardi R, Bazzocchi M, Cemal Y.
    Radiol Med; 2002 Dec; 104(5-6):412-20. PubMed ID: 12589262
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M, Suzuki H, Yamamoto T, Mamada Y, Mizuno H, Tominaga T, Suga M, Suemori S, Kato Y, Sato A, Yamanouchi E, Sakuyama K, Maeyama S, Shinagawa T, Okabe K.
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [Abstract] [Full Text] [Related]

  • 19. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
    Ge NL, Ren ZG, Ye SL, Lin ZY, Xia JL, Gan YH, Li LX, Shen YF, Tang ZY.
    Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
    [Abstract] [Full Text] [Related]

  • 20. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M.
    Cancer; 2000 Dec 15; 89(12):2606-12. PubMed ID: 11135222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.